Our breath is full of chemicals called Volatile Organic Compounds (VOCs) which are produced by metabolic processes in our bodies. These compounds can reveal a great deal about the clinical state of an individual’s health, environmental exposure, and about metabolic changes.
Breath analysis allows for timely screening which benefits practitioners in identifying health issues early, which will lead to saving healthcare resources, and more importantly, saving lives. Breathe BioMedical’s technology is being developed to be able to screen for biomarkers of disease often long before symptoms appear.
Our platform technology combines three advanced technologies to sample, digitize and analyze breath with the potential to screen for multiple diseases.
Breath samples are translated into spectral data sets using our advanced infrared spectrometer.
Our machine learning algorithm identifies disease biomarkers contained within the spectral data sets.